How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Reported Side Effects Raise Concerns for Regeneron’s Eylea February 21, 2018 Production Problems Lead Pacira to Cut Jobs in San Diego July 9, 2017 Patient Dies in Cellectis' Groundbreaking CAR-T Trial, Forcing a Halt to Trials September 4, 2017
